Merck Serono and Flamel to Collaborate on an Extended Release Formulation for Therapeutic Proteins

Lyon, France, December 20, 2007 Flamel Technologies (NASDAQ:FLML) announced that it has entered into a collaboration with Merck Serono, a division of Merck KGaA, to investigate the applicability of Flamel's Medusa® technology for the extended release of a therapeutic protein of Merck Serono's portfolio... english : Flamel's press Release - french : Merck Serono's Press Release [PDF] -